Clinical Trial: A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Treatment Protocol for Ganaxolone as add-on Therapy in Adult Patients With Uncontrolled Partial-onset Seizures Deriving Benefit From Protocol 1042-0601
Brief Summary: This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.
Detailed Summary:
Sponsor: Marinus Pharmaceuticals
Current Primary Outcome: safety as determined by adverse events [ Time Frame: one year ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Marinus Pharmaceuticals
Dates:
Date Received: October 16, 2009
Date Started: October 2009
Date Completion:
Last Updated: October 1, 2015
Last Verified: October 2015